From announcing a $10 million donation to UNICEF in support of frontline healthcare workers to joining the New Plastics Economy Global Commitment to help tackle plastic waste, Johnson & Johnson made a major impact around the world in 2018.
And it didn't go unrecognized. Among the accolades the company garnered in 2018: Acuvue Oasys® With Transitions™ Light Intelligent Technology™ contact lenses landed a spot on Time's Best Inventions of 2018 list, and Johnson & Johnson made Fortune's Change the World List for the third year running, just to name a couple.
And within the company’s proverbial walls, there was equally exciting news: Johnson & Johnson opened a new Asia Pacific headquarters in Singapore, staffed with more than 1,400 employees across our consumer, medical devices and pharmaceutical businesses, and Joe Wolk, a 20-year company veteran, took the helm as CFO, with the goal of guiding the company toward continued fiscal success.
The only way forward is through increased collaboration. It’s how we’ll tackle the largest global public health issues and continue to make progress toward a world without TB and HIV/AIDS. It’s how we’ll change the trajectory of health for humanity.
Breakthroughs. Discoveries. Aha! moments. Innovation is at the heart of how Johnson & Johnson is helping to change the trajectory of health for humanity.
In 2018 the company made strides in revolutionizing surgical procedures, improving bath time for babies and parents through cutting-edge consumer product technology, and working to defeat diseases like cancer and HIV—with a trial for a mosaic-based preventive vaccine for HIV underway in sub-Saharan Africa.
The opening of JLABS @ NYC, Johnson & Johnson Innovation's latest health sciences incubator in Manhattan, marked an exciting milestone for discovery. The hub, home to about 30 healthcare start-ups, promises to drive innovation and catalyze new scientific ideas.
When we got the study results, there was yelling and screaming. There were tears in my eyes. We are closer to a vaccine that prevents HIV than ever before.
2018 marked the 75th anniversary of the crafting of Our Credo—the Johnson & Johnson mission statement that helps guide company thinking to this day, and reflects its commitment to improving health for humanity that’s been a part of the company’s DNA since its founding.
Despite its long history, Our Credo remains a living document, which is why, in 2018, Johnson & Johnson hosted employee focus groups worldwide to ask: How can we make sure it’s relevant not just for today, but also tomorrow? The result: Key updates to the text now reflect the growing cultural awareness of the importance of diversity and transparency.
What hasn’t changed? How Johnson & Johnson employees use—and will continue to use—Our Credo as inspiration in their daily quest to help change the trajectory of human health around the globe.
My volunteer work is empowered by what I do professionally—they’re both part of the greater cause of trying to reduce human suffering through medical devices and delivery of care. That gives me a sense of mission as I go throughout my day.
In addition to its mission to create innovative healthcare solutions, Johnson & Johnson has an equally important commitment to safety.
In 2018, for instance, the company disclosed 100% of the ingredients in its Johnson's® baby products, including those found in fragrances, to ensure parents know exactly what’s in the brand’s shampoos and washes.
The company's commitment to safety is also on display at its Johnson & Johnson Institute locations around the world, which help teach healthcare professionals how to perform surgical procedures more safely.
And when it comes to patient safety, the company has made a commitment to use patient healthcare data to help improve the effectiveness of its products and the outcomes for the people who use them.
Johnson’s® fragrances are designed specifically for delicate and sensitive skin, so we avoid harsh ingredients and fragrance allergens. Our baby fragrances have been reviewed by both independent groups and safety experts—and for the first time are all listed on the Johnson’s website.
Johnson & Johnson is on a mission to help people live healthier lives every day through everything from innovative consumer care products to breakthrough medical devices and treatments for conditions ranging from dry eye to infectious diseases like tuberculosis.
In 2018, Janssen Oncology, part of the Janssen Pharmaceutical Companies of Johnson & Johnson, debuted another novel way to help support patients with the launch of Cancer.com, a one-stop digital destination designed to help guide patients and caregivers through many of the decisions they’ll have to make when faced with the disease.
I saw many patients with treatment-resistant depression who told me that friends and family believed they preferred being depressed, or weren’t trying hard enough to improve, because their antidepressants weren’t working. This isn’t about a lack of motivation. I’ve never met a patient who didn’t want to get better.
As the world’s largest healthcare company, Johnson & Johnson strives to make a powerful difference around the globe, and one way it does this is by supporting breakthrough healthcare programs—from creating new initiatives that support nurse innovators to forming partnerships with organizations like Mercy Ships, which provides free medical care to people who desperately need it.
The company also supports employees who want to do good work around the world through a new program that allows staffers to take time off to help nongovernmental organizations better reach their goals—further driving the mission of Our Credo into the future.
We know that nurses are compassionate caregivers, but they’re so much more—they’re also driving innovation and pushing healthcare forward. And we want to support and celebrate them for that.